nodes	percent_of_prediction	percent_of_DWPC	metapath
Meprobamate—ABCB1—Mitomycin—urinary bladder cancer	0.239	0.419	CbGbCtD
Meprobamate—CYP2E1—Etoposide—urinary bladder cancer	0.0973	0.17	CbGbCtD
Meprobamate—ABCB1—Gemcitabine—urinary bladder cancer	0.0689	0.121	CbGbCtD
Meprobamate—ABCB1—Cisplatin—urinary bladder cancer	0.0501	0.0877	CbGbCtD
Meprobamate—ABCB1—Etoposide—urinary bladder cancer	0.0492	0.0862	CbGbCtD
Meprobamate—ABCB1—Doxorubicin—urinary bladder cancer	0.0336	0.0588	CbGbCtD
Meprobamate—ABCB1—Methotrexate—urinary bladder cancer	0.0325	0.0569	CbGbCtD
Meprobamate—Oliguria—Thiotepa—urinary bladder cancer	0.00493	0.0116	CcSEcCtD
Meprobamate—Stomatitis—Mitomycin—urinary bladder cancer	0.00492	0.0116	CcSEcCtD
Meprobamate—Anuria—Doxorubicin—urinary bladder cancer	0.00484	0.0114	CcSEcCtD
Meprobamate—Petechiae—Gemcitabine—urinary bladder cancer	0.00464	0.0109	CcSEcCtD
Meprobamate—Dysarthria—Fluorouracil—urinary bladder cancer	0.00397	0.00933	CcSEcCtD
Meprobamate—Dysarthria—Cisplatin—urinary bladder cancer	0.00376	0.00884	CcSEcCtD
Meprobamate—Body temperature increased—Valrubicin—urinary bladder cancer	0.0037	0.00868	CcSEcCtD
Meprobamate—Syncope—Mitomycin—urinary bladder cancer	0.00354	0.00831	CcSEcCtD
Meprobamate—Leukopenia—Mitomycin—urinary bladder cancer	0.00353	0.0083	CcSEcCtD
Meprobamate—Loss of consciousness—Mitomycin—urinary bladder cancer	0.00347	0.00815	CcSEcCtD
Meprobamate—Body temperature increased—Carboplatin—urinary bladder cancer	0.00342	0.00804	CcSEcCtD
Meprobamate—Rash maculo-papular—Fluorouracil—urinary bladder cancer	0.00341	0.00802	CcSEcCtD
Meprobamate—Asthenia—Valrubicin—urinary bladder cancer	0.00336	0.00788	CcSEcCtD
Meprobamate—Pruritus—Valrubicin—urinary bladder cancer	0.00331	0.00777	CcSEcCtD
Meprobamate—Euphoric mood—Fluorouracil—urinary bladder cancer	0.00323	0.00758	CcSEcCtD
Meprobamate—Diarrhoea—Valrubicin—urinary bladder cancer	0.0032	0.00751	CcSEcCtD
Meprobamate—Shock—Mitomycin—urinary bladder cancer	0.00317	0.00744	CcSEcCtD
Meprobamate—Ataxia—Thiotepa—urinary bladder cancer	0.0031	0.00728	CcSEcCtD
Meprobamate—Dizziness—Valrubicin—urinary bladder cancer	0.00309	0.00726	CcSEcCtD
Meprobamate—Vomiting—Valrubicin—urinary bladder cancer	0.00297	0.00698	CcSEcCtD
Meprobamate—Rash maculo-papular—Etoposide—urinary bladder cancer	0.00297	0.00696	CcSEcCtD
Meprobamate—Dermatitis—Valrubicin—urinary bladder cancer	0.00295	0.00692	CcSEcCtD
Meprobamate—Headache—Valrubicin—urinary bladder cancer	0.00293	0.00688	CcSEcCtD
Meprobamate—Dermatitis bullous—Gemcitabine—urinary bladder cancer	0.0029	0.00681	CcSEcCtD
Meprobamate—Somnolence—Mitomycin—urinary bladder cancer	0.00286	0.00673	CcSEcCtD
Meprobamate—Dermatitis bullous—Fluorouracil—urinary bladder cancer	0.00285	0.0067	CcSEcCtD
Meprobamate—Nausea—Valrubicin—urinary bladder cancer	0.00278	0.00652	CcSEcCtD
Meprobamate—Ataxia—Fluorouracil—urinary bladder cancer	0.00256	0.00602	CcSEcCtD
Meprobamate—Body temperature increased—Mitomycin—urinary bladder cancer	0.00255	0.00598	CcSEcCtD
Meprobamate—Stomatitis—Thiotepa—urinary bladder cancer	0.00248	0.00582	CcSEcCtD
Meprobamate—Petechiae—Methotrexate—urinary bladder cancer	0.00238	0.00558	CcSEcCtD
Meprobamate—Agranulocytosis—Thiotepa—urinary bladder cancer	0.00237	0.00557	CcSEcCtD
Meprobamate—Bronchospasm—Gemcitabine—urinary bladder cancer	0.00236	0.00554	CcSEcCtD
Meprobamate—Eosinophilia—Fluorouracil—urinary bladder cancer	0.00233	0.00548	CcSEcCtD
Meprobamate—Asthenia—Mitomycin—urinary bladder cancer	0.00231	0.00543	CcSEcCtD
Meprobamate—Petechiae—Epirubicin—urinary bladder cancer	0.00222	0.00522	CcSEcCtD
Meprobamate—Diarrhoea—Mitomycin—urinary bladder cancer	0.0022	0.00518	CcSEcCtD
Meprobamate—Dizziness—Mitomycin—urinary bladder cancer	0.00213	0.005	CcSEcCtD
Meprobamate—Oliguria—Methotrexate—urinary bladder cancer	0.00212	0.00498	CcSEcCtD
Meprobamate—Stevens-Johnson syndrome—Gemcitabine—urinary bladder cancer	0.00212	0.00498	CcSEcCtD
Meprobamate—Stomatitis—Gemcitabine—urinary bladder cancer	0.00208	0.00489	CcSEcCtD
Meprobamate—Dysarthria—Methotrexate—urinary bladder cancer	0.00207	0.00485	CcSEcCtD
Meprobamate—Petechiae—Doxorubicin—urinary bladder cancer	0.00206	0.00483	CcSEcCtD
Meprobamate—Vomiting—Mitomycin—urinary bladder cancer	0.00205	0.00481	CcSEcCtD
Meprobamate—Stomatitis—Fluorouracil—urinary bladder cancer	0.00205	0.00481	CcSEcCtD
Meprobamate—Chills—Thiotepa—urinary bladder cancer	0.00205	0.00481	CcSEcCtD
Meprobamate—Arrhythmia—Thiotepa—urinary bladder cancer	0.00204	0.00478	CcSEcCtD
Meprobamate—Dermatitis—Mitomycin—urinary bladder cancer	0.00203	0.00477	CcSEcCtD
Meprobamate—Headache—Mitomycin—urinary bladder cancer	0.00202	0.00474	CcSEcCtD
Meprobamate—Bronchospasm—Etoposide—urinary bladder cancer	0.00201	0.00473	CcSEcCtD
Meprobamate—Agranulocytosis—Gemcitabine—urinary bladder cancer	0.00199	0.00468	CcSEcCtD
Meprobamate—Oliguria—Epirubicin—urinary bladder cancer	0.00198	0.00466	CcSEcCtD
Meprobamate—Agranulocytosis—Fluorouracil—urinary bladder cancer	0.00196	0.0046	CcSEcCtD
Meprobamate—Stomatitis—Cisplatin—urinary bladder cancer	0.00194	0.00456	CcSEcCtD
Meprobamate—Dysarthria—Epirubicin—urinary bladder cancer	0.00193	0.00454	CcSEcCtD
Meprobamate—Nausea—Mitomycin—urinary bladder cancer	0.00191	0.00449	CcSEcCtD
Meprobamate—Oedema peripheral—Gemcitabine—urinary bladder cancer	0.00189	0.00444	CcSEcCtD
Meprobamate—Oliguria—Doxorubicin—urinary bladder cancer	0.00184	0.00431	CcSEcCtD
Meprobamate—Aplastic anaemia—Methotrexate—urinary bladder cancer	0.00183	0.00431	CcSEcCtD
Meprobamate—Agitation—Thiotepa—urinary bladder cancer	0.00182	0.00428	CcSEcCtD
Meprobamate—Erythema multiforme—Gemcitabine—urinary bladder cancer	0.00181	0.00426	CcSEcCtD
Meprobamate—Stevens-Johnson syndrome—Etoposide—urinary bladder cancer	0.00181	0.00425	CcSEcCtD
Meprobamate—Dysarthria—Doxorubicin—urinary bladder cancer	0.00179	0.0042	CcSEcCtD
Meprobamate—Stomatitis—Etoposide—urinary bladder cancer	0.00178	0.00418	CcSEcCtD
Meprobamate—Leukopenia—Thiotepa—urinary bladder cancer	0.00178	0.00417	CcSEcCtD
Meprobamate—Ecchymosis—Methotrexate—urinary bladder cancer	0.00177	0.00415	CcSEcCtD
Meprobamate—Chills—Gemcitabine—urinary bladder cancer	0.00172	0.00404	CcSEcCtD
Meprobamate—Aplastic anaemia—Epirubicin—urinary bladder cancer	0.00172	0.00403	CcSEcCtD
Meprobamate—Arrhythmia—Gemcitabine—urinary bladder cancer	0.00171	0.00402	CcSEcCtD
Meprobamate—Agranulocytosis—Etoposide—urinary bladder cancer	0.0017	0.004	CcSEcCtD
Meprobamate—Arrhythmia—Fluorouracil—urinary bladder cancer	0.00169	0.00396	CcSEcCtD
Meprobamate—Lymphadenopathy—Methotrexate—urinary bladder cancer	0.00166	0.0039	CcSEcCtD
Meprobamate—Rash maculo-papular—Epirubicin—urinary bladder cancer	0.00166	0.0039	CcSEcCtD
Meprobamate—Ecchymosis—Epirubicin—urinary bladder cancer	0.00165	0.00388	CcSEcCtD
Meprobamate—Arrhythmia—Cisplatin—urinary bladder cancer	0.0016	0.00375	CcSEcCtD
Meprobamate—Aplastic anaemia—Doxorubicin—urinary bladder cancer	0.00159	0.00373	CcSEcCtD
Meprobamate—Tachycardia—Thiotepa—urinary bladder cancer	0.00158	0.00371	CcSEcCtD
Meprobamate—Lymphadenopathy—Epirubicin—urinary bladder cancer	0.00156	0.00365	CcSEcCtD
Meprobamate—Erythema multiforme—Etoposide—urinary bladder cancer	0.00155	0.00364	CcSEcCtD
Meprobamate—Rash maculo-papular—Doxorubicin—urinary bladder cancer	0.00154	0.00361	CcSEcCtD
Meprobamate—Ecchymosis—Doxorubicin—urinary bladder cancer	0.00153	0.00359	CcSEcCtD
Meprobamate—Dermatitis exfoliative—Methotrexate—urinary bladder cancer	0.0015	0.00353	CcSEcCtD
Meprobamate—Leukopenia—Gemcitabine—urinary bladder cancer	0.00149	0.00351	CcSEcCtD
Meprobamate—Vascular purpura—Epirubicin—urinary bladder cancer	0.00148	0.00348	CcSEcCtD
Meprobamate—Chills—Etoposide—urinary bladder cancer	0.00147	0.00345	CcSEcCtD
Meprobamate—Leukopenia—Fluorouracil—urinary bladder cancer	0.00147	0.00345	CcSEcCtD
Meprobamate—Paraesthesia—Thiotepa—urinary bladder cancer	0.00145	0.00342	CcSEcCtD
Meprobamate—Somnolence—Thiotepa—urinary bladder cancer	0.00144	0.00338	CcSEcCtD
Meprobamate—Lymphadenopathy—Doxorubicin—urinary bladder cancer	0.00144	0.00338	CcSEcCtD
Meprobamate—Dermatitis exfoliative—Epirubicin—urinary bladder cancer	0.00141	0.0033	CcSEcCtD
Meprobamate—Leukopenia—Cisplatin—urinary bladder cancer	0.00139	0.00327	CcSEcCtD
Meprobamate—Dermatitis bullous—Epirubicin—urinary bladder cancer	0.00139	0.00326	CcSEcCtD
Meprobamate—Purpura—Epirubicin—urinary bladder cancer	0.00138	0.00323	CcSEcCtD
Meprobamate—Vascular purpura—Doxorubicin—urinary bladder cancer	0.00137	0.00322	CcSEcCtD
Meprobamate—Anaphylactic shock—Gemcitabine—urinary bladder cancer	0.00136	0.0032	CcSEcCtD
Meprobamate—Anaphylactic shock—Fluorouracil—urinary bladder cancer	0.00134	0.00315	CcSEcCtD
Meprobamate—Ataxia—Methotrexate—urinary bladder cancer	0.00133	0.00313	CcSEcCtD
Meprobamate—Tachycardia—Fluorouracil—urinary bladder cancer	0.00131	0.00307	CcSEcCtD
Meprobamate—Dermatitis exfoliative—Doxorubicin—urinary bladder cancer	0.0013	0.00306	CcSEcCtD
Meprobamate—Dermatitis bullous—Doxorubicin—urinary bladder cancer	0.00129	0.00302	CcSEcCtD
Meprobamate—Vertigo—Etoposide—urinary bladder cancer	0.00128	0.00301	CcSEcCtD
Meprobamate—Body temperature increased—Thiotepa—urinary bladder cancer	0.00128	0.00301	CcSEcCtD
Meprobamate—Leukopenia—Etoposide—urinary bladder cancer	0.00128	0.003	CcSEcCtD
Meprobamate—Purpura—Doxorubicin—urinary bladder cancer	0.00127	0.00299	CcSEcCtD
Meprobamate—Hypotension—Gemcitabine—urinary bladder cancer	0.00127	0.00299	CcSEcCtD
Meprobamate—Anaphylactic shock—Cisplatin—urinary bladder cancer	0.00127	0.00298	CcSEcCtD
Meprobamate—Loss of consciousness—Etoposide—urinary bladder cancer	0.00125	0.00294	CcSEcCtD
Meprobamate—Hypotension—Fluorouracil—urinary bladder cancer	0.00125	0.00294	CcSEcCtD
Meprobamate—Ataxia—Epirubicin—urinary bladder cancer	0.00125	0.00293	CcSEcCtD
Meprobamate—Tachycardia—Cisplatin—urinary bladder cancer	0.00124	0.00291	CcSEcCtD
Meprobamate—Paraesthesia—Gemcitabine—urinary bladder cancer	0.00122	0.00287	CcSEcCtD
Meprobamate—Eosinophilia—Methotrexate—urinary bladder cancer	0.00121	0.00285	CcSEcCtD
Meprobamate—Somnolence—Gemcitabine—urinary bladder cancer	0.00121	0.00285	CcSEcCtD
Meprobamate—Paraesthesia—Fluorouracil—urinary bladder cancer	0.0012	0.00283	CcSEcCtD
Meprobamate—Hypersensitivity—Thiotepa—urinary bladder cancer	0.00119	0.0028	CcSEcCtD
Meprobamate—Somnolence—Fluorouracil—urinary bladder cancer	0.00119	0.0028	CcSEcCtD
Meprobamate—Hypotension—Cisplatin—urinary bladder cancer	0.00119	0.00279	CcSEcCtD
Meprobamate—Anaphylactic shock—Etoposide—urinary bladder cancer	0.00116	0.00273	CcSEcCtD
Meprobamate—Asthenia—Thiotepa—urinary bladder cancer	0.00116	0.00273	CcSEcCtD
Meprobamate—Ataxia—Doxorubicin—urinary bladder cancer	0.00115	0.00271	CcSEcCtD
Meprobamate—Pruritus—Thiotepa—urinary bladder cancer	0.00115	0.00269	CcSEcCtD
Meprobamate—Paraesthesia—Cisplatin—urinary bladder cancer	0.00114	0.00268	CcSEcCtD
Meprobamate—Tachycardia—Etoposide—urinary bladder cancer	0.00114	0.00267	CcSEcCtD
Meprobamate—Eosinophilia—Epirubicin—urinary bladder cancer	0.00114	0.00267	CcSEcCtD
Meprobamate—Diarrhoea—Thiotepa—urinary bladder cancer	0.00111	0.0026	CcSEcCtD
Meprobamate—Drowsiness—Methotrexate—urinary bladder cancer	0.00109	0.00257	CcSEcCtD
Meprobamate—Hypotension—Etoposide—urinary bladder cancer	0.00109	0.00255	CcSEcCtD
Meprobamate—Stevens-Johnson syndrome—Methotrexate—urinary bladder cancer	0.00108	0.00254	CcSEcCtD
Meprobamate—Body temperature increased—Gemcitabine—urinary bladder cancer	0.00108	0.00253	CcSEcCtD
Meprobamate—Dizziness—Thiotepa—urinary bladder cancer	0.00107	0.00252	CcSEcCtD
Meprobamate—Stomatitis—Methotrexate—urinary bladder cancer	0.00107	0.0025	CcSEcCtD
Meprobamate—Body temperature increased—Fluorouracil—urinary bladder cancer	0.00106	0.00249	CcSEcCtD
Meprobamate—Eosinophilia—Doxorubicin—urinary bladder cancer	0.00105	0.00247	CcSEcCtD
Meprobamate—Paraesthesia—Etoposide—urinary bladder cancer	0.00105	0.00245	CcSEcCtD
Meprobamate—Somnolence—Etoposide—urinary bladder cancer	0.00103	0.00243	CcSEcCtD
Meprobamate—Vomiting—Thiotepa—urinary bladder cancer	0.00103	0.00242	CcSEcCtD
Meprobamate—Drowsiness—Epirubicin—urinary bladder cancer	0.00102	0.0024	CcSEcCtD
Meprobamate—Dermatitis—Thiotepa—urinary bladder cancer	0.00102	0.0024	CcSEcCtD
Meprobamate—Agranulocytosis—Methotrexate—urinary bladder cancer	0.00102	0.0024	CcSEcCtD
Meprobamate—Headache—Thiotepa—urinary bladder cancer	0.00102	0.00238	CcSEcCtD
Meprobamate—Stevens-Johnson syndrome—Epirubicin—urinary bladder cancer	0.00101	0.00238	CcSEcCtD
Meprobamate—Body temperature increased—Cisplatin—urinary bladder cancer	0.001	0.00236	CcSEcCtD
Meprobamate—Stomatitis—Epirubicin—urinary bladder cancer	0.000997	0.00234	CcSEcCtD
Meprobamate—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.000987	0.00232	CcSEcCtD
Meprobamate—Asthenia—Gemcitabine—urinary bladder cancer	0.000978	0.0023	CcSEcCtD
Meprobamate—Pruritus—Gemcitabine—urinary bladder cancer	0.000964	0.00226	CcSEcCtD
Meprobamate—Nausea—Thiotepa—urinary bladder cancer	0.000962	0.00226	CcSEcCtD
Meprobamate—Agranulocytosis—Epirubicin—urinary bladder cancer	0.000955	0.00224	CcSEcCtD
Meprobamate—Pruritus—Fluorouracil—urinary bladder cancer	0.000948	0.00223	CcSEcCtD
Meprobamate—Drowsiness—Doxorubicin—urinary bladder cancer	0.000946	0.00222	CcSEcCtD
Meprobamate—Stevens-Johnson syndrome—Doxorubicin—urinary bladder cancer	0.000938	0.0022	CcSEcCtD
Meprobamate—Hypersensitivity—Cisplatin—urinary bladder cancer	0.000936	0.0022	CcSEcCtD
Meprobamate—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000933	0.00219	CcSEcCtD
Meprobamate—Erythema multiforme—Methotrexate—urinary bladder cancer	0.000928	0.00218	CcSEcCtD
Meprobamate—Stomatitis—Doxorubicin—urinary bladder cancer	0.000923	0.00217	CcSEcCtD
Meprobamate—Body temperature increased—Etoposide—urinary bladder cancer	0.00092	0.00216	CcSEcCtD
Meprobamate—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000917	0.00215	CcSEcCtD
Meprobamate—Asthenia—Cisplatin—urinary bladder cancer	0.000911	0.00214	CcSEcCtD
Meprobamate—Oedema peripheral—Epirubicin—urinary bladder cancer	0.000905	0.00212	CcSEcCtD
Meprobamate—Dizziness—Fluorouracil—urinary bladder cancer	0.000886	0.00208	CcSEcCtD
Meprobamate—Agranulocytosis—Doxorubicin—urinary bladder cancer	0.000883	0.00207	CcSEcCtD
Meprobamate—Chills—Methotrexate—urinary bladder cancer	0.00088	0.00207	CcSEcCtD
Meprobamate—Diarrhoea—Cisplatin—urinary bladder cancer	0.000869	0.00204	CcSEcCtD
Meprobamate—Erythema multiforme—Epirubicin—urinary bladder cancer	0.000868	0.00204	CcSEcCtD
Meprobamate—Vomiting—Gemcitabine—urinary bladder cancer	0.000867	0.00204	CcSEcCtD
Meprobamate—Dermatitis—Gemcitabine—urinary bladder cancer	0.000859	0.00202	CcSEcCtD
Meprobamate—Hypersensitivity—Etoposide—urinary bladder cancer	0.000857	0.00201	CcSEcCtD
Meprobamate—Headache—Gemcitabine—urinary bladder cancer	0.000854	0.00201	CcSEcCtD
Meprobamate—Vomiting—Fluorouracil—urinary bladder cancer	0.000852	0.002	CcSEcCtD
Meprobamate—Dermatitis—Fluorouracil—urinary bladder cancer	0.000844	0.00198	CcSEcCtD
Meprobamate—Headache—Fluorouracil—urinary bladder cancer	0.00084	0.00197	CcSEcCtD
Meprobamate—Oedema peripheral—Doxorubicin—urinary bladder cancer	0.000837	0.00197	CcSEcCtD
Meprobamate—Asthenia—Etoposide—urinary bladder cancer	0.000835	0.00196	CcSEcCtD
Meprobamate—Chills—Epirubicin—urinary bladder cancer	0.000824	0.00193	CcSEcCtD
Meprobamate—Pruritus—Etoposide—urinary bladder cancer	0.000823	0.00193	CcSEcCtD
Meprobamate—Arrhythmia—Epirubicin—urinary bladder cancer	0.00082	0.00193	CcSEcCtD
Meprobamate—Nausea—Gemcitabine—urinary bladder cancer	0.00081	0.0019	CcSEcCtD
Meprobamate—Vomiting—Cisplatin—urinary bladder cancer	0.000808	0.0019	CcSEcCtD
Meprobamate—Erythema multiforme—Doxorubicin—urinary bladder cancer	0.000803	0.00189	CcSEcCtD
Meprobamate—Dermatitis—Cisplatin—urinary bladder cancer	0.0008	0.00188	CcSEcCtD
Meprobamate—Diarrhoea—Etoposide—urinary bladder cancer	0.000796	0.00187	CcSEcCtD
Meprobamate—Nausea—Fluorouracil—urinary bladder cancer	0.000796	0.00187	CcSEcCtD
Meprobamate—Dizziness—Etoposide—urinary bladder cancer	0.00077	0.00181	CcSEcCtD
Meprobamate—Vertigo—Methotrexate—urinary bladder cancer	0.000767	0.0018	CcSEcCtD
Meprobamate—Leukopenia—Methotrexate—urinary bladder cancer	0.000765	0.0018	CcSEcCtD
Meprobamate—Chills—Doxorubicin—urinary bladder cancer	0.000762	0.00179	CcSEcCtD
Meprobamate—Arrhythmia—Doxorubicin—urinary bladder cancer	0.000759	0.00178	CcSEcCtD
Meprobamate—Nausea—Cisplatin—urinary bladder cancer	0.000755	0.00177	CcSEcCtD
Meprobamate—Vomiting—Etoposide—urinary bladder cancer	0.00074	0.00174	CcSEcCtD
Meprobamate—Agitation—Epirubicin—urinary bladder cancer	0.000735	0.00173	CcSEcCtD
Meprobamate—Dermatitis—Etoposide—urinary bladder cancer	0.000733	0.00172	CcSEcCtD
Meprobamate—Headache—Etoposide—urinary bladder cancer	0.000729	0.00171	CcSEcCtD
Meprobamate—Vertigo—Epirubicin—urinary bladder cancer	0.000718	0.00169	CcSEcCtD
Meprobamate—Syncope—Epirubicin—urinary bladder cancer	0.000717	0.00168	CcSEcCtD
Meprobamate—Leukopenia—Epirubicin—urinary bladder cancer	0.000716	0.00168	CcSEcCtD
Meprobamate—Palpitations—Epirubicin—urinary bladder cancer	0.000706	0.00166	CcSEcCtD
Meprobamate—Loss of consciousness—Epirubicin—urinary bladder cancer	0.000703	0.00165	CcSEcCtD
Meprobamate—Anaphylactic shock—Methotrexate—urinary bladder cancer	0.000697	0.00164	CcSEcCtD
Meprobamate—Nausea—Etoposide—urinary bladder cancer	0.000691	0.00162	CcSEcCtD
Meprobamate—Agitation—Doxorubicin—urinary bladder cancer	0.00068	0.0016	CcSEcCtD
Meprobamate—Vertigo—Doxorubicin—urinary bladder cancer	0.000665	0.00156	CcSEcCtD
Meprobamate—Syncope—Doxorubicin—urinary bladder cancer	0.000663	0.00156	CcSEcCtD
Meprobamate—Leukopenia—Doxorubicin—urinary bladder cancer	0.000662	0.00155	CcSEcCtD
Meprobamate—Palpitations—Doxorubicin—urinary bladder cancer	0.000654	0.00154	CcSEcCtD
Meprobamate—Anaphylactic shock—Epirubicin—urinary bladder cancer	0.000652	0.00153	CcSEcCtD
Meprobamate—Hypotension—Methotrexate—urinary bladder cancer	0.000651	0.00153	CcSEcCtD
Meprobamate—Loss of consciousness—Doxorubicin—urinary bladder cancer	0.00065	0.00153	CcSEcCtD
Meprobamate—Shock—Epirubicin—urinary bladder cancer	0.000642	0.00151	CcSEcCtD
Meprobamate—Tachycardia—Epirubicin—urinary bladder cancer	0.000637	0.0015	CcSEcCtD
Meprobamate—Paraesthesia—Methotrexate—urinary bladder cancer	0.000626	0.00147	CcSEcCtD
Meprobamate—Somnolence—Methotrexate—urinary bladder cancer	0.00062	0.00146	CcSEcCtD
Meprobamate—Hypotension—Epirubicin—urinary bladder cancer	0.00061	0.00143	CcSEcCtD
Meprobamate—Anaphylactic shock—Doxorubicin—urinary bladder cancer	0.000604	0.00142	CcSEcCtD
Meprobamate—Shock—Doxorubicin—urinary bladder cancer	0.000594	0.00139	CcSEcCtD
Meprobamate—Tachycardia—Doxorubicin—urinary bladder cancer	0.000589	0.00138	CcSEcCtD
Meprobamate—Paraesthesia—Epirubicin—urinary bladder cancer	0.000586	0.00138	CcSEcCtD
Meprobamate—Somnolence—Epirubicin—urinary bladder cancer	0.00058	0.00136	CcSEcCtD
Meprobamate—Hypotension—Doxorubicin—urinary bladder cancer	0.000564	0.00132	CcSEcCtD
Meprobamate—Body temperature increased—Methotrexate—urinary bladder cancer	0.000551	0.00129	CcSEcCtD
Meprobamate—Paraesthesia—Doxorubicin—urinary bladder cancer	0.000542	0.00127	CcSEcCtD
Meprobamate—Somnolence—Doxorubicin—urinary bladder cancer	0.000537	0.00126	CcSEcCtD
Meprobamate—Body temperature increased—Epirubicin—urinary bladder cancer	0.000516	0.00121	CcSEcCtD
Meprobamate—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000514	0.00121	CcSEcCtD
Meprobamate—Asthenia—Methotrexate—urinary bladder cancer	0.0005	0.00117	CcSEcCtD
Meprobamate—Pruritus—Methotrexate—urinary bladder cancer	0.000493	0.00116	CcSEcCtD
Meprobamate—Hypersensitivity—Epirubicin—urinary bladder cancer	0.000481	0.00113	CcSEcCtD
Meprobamate—Body temperature increased—Doxorubicin—urinary bladder cancer	0.000477	0.00112	CcSEcCtD
Meprobamate—Diarrhoea—Methotrexate—urinary bladder cancer	0.000477	0.00112	CcSEcCtD
Meprobamate—Asthenia—Epirubicin—urinary bladder cancer	0.000468	0.0011	CcSEcCtD
Meprobamate—Pruritus—Epirubicin—urinary bladder cancer	0.000462	0.00108	CcSEcCtD
Meprobamate—Dizziness—Methotrexate—urinary bladder cancer	0.000461	0.00108	CcSEcCtD
Meprobamate—Diarrhoea—Epirubicin—urinary bladder cancer	0.000446	0.00105	CcSEcCtD
Meprobamate—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.000445	0.00104	CcSEcCtD
Meprobamate—Vomiting—Methotrexate—urinary bladder cancer	0.000443	0.00104	CcSEcCtD
Meprobamate—Dermatitis—Methotrexate—urinary bladder cancer	0.000439	0.00103	CcSEcCtD
Meprobamate—Headache—Methotrexate—urinary bladder cancer	0.000437	0.00103	CcSEcCtD
Meprobamate—Asthenia—Doxorubicin—urinary bladder cancer	0.000433	0.00102	CcSEcCtD
Meprobamate—Dizziness—Epirubicin—urinary bladder cancer	0.000431	0.00101	CcSEcCtD
Meprobamate—Pruritus—Doxorubicin—urinary bladder cancer	0.000427	0.001	CcSEcCtD
Meprobamate—Vomiting—Epirubicin—urinary bladder cancer	0.000415	0.000974	CcSEcCtD
Meprobamate—Nausea—Methotrexate—urinary bladder cancer	0.000414	0.000972	CcSEcCtD
Meprobamate—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000413	0.00097	CcSEcCtD
Meprobamate—Dermatitis—Epirubicin—urinary bladder cancer	0.000411	0.000965	CcSEcCtD
Meprobamate—Headache—Epirubicin—urinary bladder cancer	0.000409	0.00096	CcSEcCtD
Meprobamate—Dizziness—Doxorubicin—urinary bladder cancer	0.000399	0.000937	CcSEcCtD
Meprobamate—Nausea—Epirubicin—urinary bladder cancer	0.000388	0.00091	CcSEcCtD
Meprobamate—Vomiting—Doxorubicin—urinary bladder cancer	0.000384	0.000901	CcSEcCtD
Meprobamate—Dermatitis—Doxorubicin—urinary bladder cancer	0.00038	0.000893	CcSEcCtD
Meprobamate—Headache—Doxorubicin—urinary bladder cancer	0.000378	0.000888	CcSEcCtD
Meprobamate—Nausea—Doxorubicin—urinary bladder cancer	0.000359	0.000842	CcSEcCtD
Meprobamate—ABCB1—Constitutive Androstane Receptor Pathway—SMC1A—urinary bladder cancer	3.33e-05	0.0101	CbGpPWpGaD
Meprobamate—GABRA5—Ion channel transport—TRPV1—urinary bladder cancer	3.23e-05	0.00978	CbGpPWpGaD
Meprobamate—GABRA3—Ion channel transport—TRPV1—urinary bladder cancer	3.17e-05	0.0096	CbGpPWpGaD
Meprobamate—GABRA2—Ion channel transport—TRPV1—urinary bladder cancer	3.11e-05	0.00943	CbGpPWpGaD
Meprobamate—GABRB3—Ion channel transport—TRPV1—urinary bladder cancer	3.09e-05	0.00937	CbGpPWpGaD
Meprobamate—GABRG2—Ion channel transport—TRPV1—urinary bladder cancer	3.04e-05	0.0092	CbGpPWpGaD
Meprobamate—CYP2E1—Biological oxidations—GSTZ1—urinary bladder cancer	3.02e-05	0.00914	CbGpPWpGaD
Meprobamate—CYP2E1—Metapathway biotransformation—GSTZ1—urinary bladder cancer	2.98e-05	0.00902	CbGpPWpGaD
Meprobamate—CYP2E1—Biological oxidations—GSTO2—urinary bladder cancer	2.86e-05	0.00867	CbGpPWpGaD
Meprobamate—CYP2E1—Biological oxidations—NAT1—urinary bladder cancer	2.86e-05	0.00867	CbGpPWpGaD
Meprobamate—CYP2E1—Metapathway biotransformation—GSTO2—urinary bladder cancer	2.82e-05	0.00855	CbGpPWpGaD
Meprobamate—GABRA1—Ion channel transport—TRPV1—urinary bladder cancer	2.66e-05	0.00804	CbGpPWpGaD
Meprobamate—CYP2E1—Biological oxidations—UGT2B7—urinary bladder cancer	2.62e-05	0.00793	CbGpPWpGaD
Meprobamate—CYP2C19—Arachidonic acid metabolism—HPGDS—urinary bladder cancer	2.6e-05	0.00787	CbGpPWpGaD
Meprobamate—CYP2E1—Metapathway biotransformation—UGT2B7—urinary bladder cancer	2.58e-05	0.00782	CbGpPWpGaD
Meprobamate—CYP2E1—Biological oxidations—CYP4B1—urinary bladder cancer	2.36e-05	0.00714	CbGpPWpGaD
Meprobamate—CYP2C19—Biological oxidations—GSTZ1—urinary bladder cancer	2.33e-05	0.00705	CbGpPWpGaD
Meprobamate—CYP2E1—Metapathway biotransformation—CYP4B1—urinary bladder cancer	2.32e-05	0.00704	CbGpPWpGaD
Meprobamate—CYP2C19—Metapathway biotransformation—GSTZ1—urinary bladder cancer	2.3e-05	0.00696	CbGpPWpGaD
Meprobamate—CYP2C19—Biological oxidations—GSTO2—urinary bladder cancer	2.21e-05	0.00669	CbGpPWpGaD
Meprobamate—CYP2C19—Biological oxidations—NAT1—urinary bladder cancer	2.21e-05	0.00669	CbGpPWpGaD
Meprobamate—CYP2C19—Metapathway biotransformation—GSTO2—urinary bladder cancer	2.18e-05	0.00659	CbGpPWpGaD
Meprobamate—GABRA6—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	2.17e-05	0.00658	CbGpPWpGaD
Meprobamate—GABRA4—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	2.14e-05	0.0065	CbGpPWpGaD
Meprobamate—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—urinary bladder cancer	2.03e-05	0.00615	CbGpPWpGaD
Meprobamate—CYP2C19—Biological oxidations—UGT2B7—urinary bladder cancer	2.02e-05	0.00612	CbGpPWpGaD
Meprobamate—CYP2C19—Metapathway biotransformation—UGT2B7—urinary bladder cancer	1.99e-05	0.00603	CbGpPWpGaD
Meprobamate—GABRA5—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	1.91e-05	0.00577	CbGpPWpGaD
Meprobamate—GABRA3—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	1.87e-05	0.00567	CbGpPWpGaD
Meprobamate—ABCB1—HIF-1-alpha transcription factor network—TFRC—urinary bladder cancer	1.85e-05	0.00559	CbGpPWpGaD
Meprobamate—GABRA2—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	1.84e-05	0.00557	CbGpPWpGaD
Meprobamate—GABRB3—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	1.83e-05	0.00553	CbGpPWpGaD
Meprobamate—CYP2C19—Biological oxidations—CYP4B1—urinary bladder cancer	1.82e-05	0.00551	CbGpPWpGaD
Meprobamate—GABRG2—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	1.79e-05	0.00544	CbGpPWpGaD
Meprobamate—CYP2C19—Metapathway biotransformation—CYP4B1—urinary bladder cancer	1.79e-05	0.00543	CbGpPWpGaD
Meprobamate—GABRA6—Orphan transporters—CREBBP—urinary bladder cancer	1.66e-05	0.00502	CbGpPWpGaD
Meprobamate—GABRA4—Orphan transporters—CREBBP—urinary bladder cancer	1.64e-05	0.00496	CbGpPWpGaD
Meprobamate—GABRA1—SIDS Susceptibility Pathways—ESR2—urinary bladder cancer	1.63e-05	0.00493	CbGpPWpGaD
Meprobamate—GABRA6—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	1.57e-05	0.00476	CbGpPWpGaD
Meprobamate—GABRA1—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	1.57e-05	0.00475	CbGpPWpGaD
Meprobamate—CYP2E1—Biological oxidations—NAT2—urinary bladder cancer	1.57e-05	0.00475	CbGpPWpGaD
Meprobamate—GABRA4—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	1.55e-05	0.0047	CbGpPWpGaD
Meprobamate—CYP2E1—Metapathway biotransformation—NAT2—urinary bladder cancer	1.55e-05	0.00468	CbGpPWpGaD
Meprobamate—CYP2C19—Arachidonic acid metabolism—GPX1—urinary bladder cancer	1.54e-05	0.00466	CbGpPWpGaD
Meprobamate—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—urinary bladder cancer	1.53e-05	0.00463	CbGpPWpGaD
Meprobamate—GABRA5—Orphan transporters—CREBBP—urinary bladder cancer	1.45e-05	0.00441	CbGpPWpGaD
Meprobamate—GABRA3—Orphan transporters—CREBBP—urinary bladder cancer	1.43e-05	0.00433	CbGpPWpGaD
Meprobamate—GABRA2—Orphan transporters—CREBBP—urinary bladder cancer	1.4e-05	0.00425	CbGpPWpGaD
Meprobamate—GABRB3—Orphan transporters—CREBBP—urinary bladder cancer	1.39e-05	0.00422	CbGpPWpGaD
Meprobamate—GABRA5—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	1.38e-05	0.00417	CbGpPWpGaD
Meprobamate—GABRG2—Orphan transporters—CREBBP—urinary bladder cancer	1.37e-05	0.00415	CbGpPWpGaD
Meprobamate—GABRA3—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	1.35e-05	0.0041	CbGpPWpGaD
Meprobamate—GABRA2—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	1.33e-05	0.00403	CbGpPWpGaD
Meprobamate—GABRB3—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	1.32e-05	0.004	CbGpPWpGaD
Meprobamate—GABRG2—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	1.3e-05	0.00393	CbGpPWpGaD
Meprobamate—GABRA6—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	1.28e-05	0.00388	CbGpPWpGaD
Meprobamate—GABRA4—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	1.26e-05	0.00383	CbGpPWpGaD
Meprobamate—CYP2E1—Biological oxidations—HPGDS—urinary bladder cancer	1.25e-05	0.0038	CbGpPWpGaD
Meprobamate—CYP2E1—Biological oxidations—GSTT1—urinary bladder cancer	1.22e-05	0.00368	CbGpPWpGaD
Meprobamate—CYP2C19—Biological oxidations—NAT2—urinary bladder cancer	1.21e-05	0.00366	CbGpPWpGaD
Meprobamate—GABRA1—Orphan transporters—CREBBP—urinary bladder cancer	1.2e-05	0.00363	CbGpPWpGaD
Meprobamate—CYP2C19—Metapathway biotransformation—NAT2—urinary bladder cancer	1.19e-05	0.00361	CbGpPWpGaD
Meprobamate—ABCB1—Integrated Pancreatic Cancer Pathway—LIG1—urinary bladder cancer	1.14e-05	0.00345	CbGpPWpGaD
Meprobamate—GABRA1—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	1.13e-05	0.00343	CbGpPWpGaD
Meprobamate—GABRA5—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	1.12e-05	0.0034	CbGpPWpGaD
Meprobamate—ABCB1—HIF-1-alpha transcription factor network—TERT—urinary bladder cancer	1.11e-05	0.00335	CbGpPWpGaD
Meprobamate—GABRA3—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	1.1e-05	0.00334	CbGpPWpGaD
Meprobamate—GABRA2—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	1.08e-05	0.00328	CbGpPWpGaD
Meprobamate—GABRB3—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	1.08e-05	0.00326	CbGpPWpGaD
Meprobamate—GABRG2—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	1.06e-05	0.0032	CbGpPWpGaD
Meprobamate—ABCB1—Allograft Rejection—FAS—urinary bladder cancer	9.74e-06	0.00295	CbGpPWpGaD
Meprobamate—CYP2C19—Biological oxidations—HPGDS—urinary bladder cancer	9.67e-06	0.00293	CbGpPWpGaD
Meprobamate—CYP2C19—Biological oxidations—GSTT1—urinary bladder cancer	9.38e-06	0.00284	CbGpPWpGaD
Meprobamate—GABRA1—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	9.24e-06	0.0028	CbGpPWpGaD
Meprobamate—CYP2C19—Arachidonic acid metabolism—PTGS2—urinary bladder cancer	9.05e-06	0.00274	CbGpPWpGaD
Meprobamate—ABCB1—Integrated Pancreatic Cancer Pathway—HPGDS—urinary bladder cancer	8.68e-06	0.00263	CbGpPWpGaD
Meprobamate—GABRA1—SIDS Susceptibility Pathways—CREBBP—urinary bladder cancer	8.65e-06	0.00262	CbGpPWpGaD
Meprobamate—GABRA6—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	8.65e-06	0.00262	CbGpPWpGaD
Meprobamate—ABCB1—HIF-1-alpha transcription factor network—CREBBP—urinary bladder cancer	8.63e-06	0.00262	CbGpPWpGaD
Meprobamate—ABCB1—Integrated Pancreatic Cancer Pathway—IGFBP3—urinary bladder cancer	8.62e-06	0.00261	CbGpPWpGaD
Meprobamate—GABRA4—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	8.54e-06	0.00259	CbGpPWpGaD
Meprobamate—CYP2E1—Biological oxidations—GSTP1—urinary bladder cancer	8.42e-06	0.00255	CbGpPWpGaD
Meprobamate—CYP2E1—Metapathway biotransformation—GSTP1—urinary bladder cancer	8.31e-06	0.00252	CbGpPWpGaD
Meprobamate—ABCB1—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	7.86e-06	0.00238	CbGpPWpGaD
Meprobamate—CYP2E1—Biological oxidations—GSTM1—urinary bladder cancer	7.74e-06	0.00235	CbGpPWpGaD
Meprobamate—CYP2E1—Metapathway biotransformation—GSTM1—urinary bladder cancer	7.63e-06	0.00231	CbGpPWpGaD
Meprobamate—GABRA5—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	7.59e-06	0.0023	CbGpPWpGaD
Meprobamate—GABRA3—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	7.45e-06	0.00226	CbGpPWpGaD
Meprobamate—GABRA2—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	7.32e-06	0.00222	CbGpPWpGaD
Meprobamate—GABRB3—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	7.27e-06	0.0022	CbGpPWpGaD
Meprobamate—GABRG2—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	7.14e-06	0.00216	CbGpPWpGaD
Meprobamate—GABRB3—BDNF signaling pathway—SRC—urinary bladder cancer	7.12e-06	0.00216	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	6.98e-06	0.00211	CbGpPWpGaD
Meprobamate—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—urinary bladder cancer	6.94e-06	0.0021	CbGpPWpGaD
Meprobamate—GABRA1—SIDS Susceptibility Pathways—CXCL8—urinary bladder cancer	6.87e-06	0.00208	CbGpPWpGaD
Meprobamate—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—urinary bladder cancer	6.5e-06	0.00197	CbGpPWpGaD
Meprobamate—CYP2C19—Biological oxidations—GSTP1—urinary bladder cancer	6.5e-06	0.00197	CbGpPWpGaD
Meprobamate—CYP2C19—Metapathway biotransformation—GSTP1—urinary bladder cancer	6.41e-06	0.00194	CbGpPWpGaD
Meprobamate—GABRA1—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	6.24e-06	0.00189	CbGpPWpGaD
Meprobamate—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—urinary bladder cancer	6.09e-06	0.00185	CbGpPWpGaD
Meprobamate—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—urinary bladder cancer	6.01e-06	0.00182	CbGpPWpGaD
Meprobamate—CYP2C19—Biological oxidations—GSTM1—urinary bladder cancer	5.97e-06	0.00181	CbGpPWpGaD
Meprobamate—ABCB1—Allograft Rejection—CXCL8—urinary bladder cancer	5.94e-06	0.0018	CbGpPWpGaD
Meprobamate—GABRA1—SIDS Susceptibility Pathways—EP300—urinary bladder cancer	5.89e-06	0.00179	CbGpPWpGaD
Meprobamate—CYP2C19—Metapathway biotransformation—GSTM1—urinary bladder cancer	5.89e-06	0.00178	CbGpPWpGaD
Meprobamate—ABCB1—HIF-1-alpha transcription factor network—EP300—urinary bladder cancer	5.88e-06	0.00178	CbGpPWpGaD
Meprobamate—ABCB1—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	5.69e-06	0.00172	CbGpPWpGaD
Meprobamate—ABCB1—Allograft Rejection—IL2—urinary bladder cancer	5.68e-06	0.00172	CbGpPWpGaD
Meprobamate—ABCB1—Integrated Pancreatic Cancer Pathway—CCNE1—urinary bladder cancer	5.52e-06	0.00167	CbGpPWpGaD
Meprobamate—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—urinary bladder cancer	5.42e-06	0.00164	CbGpPWpGaD
Meprobamate—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—urinary bladder cancer	5.34e-06	0.00162	CbGpPWpGaD
Meprobamate—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—urinary bladder cancer	5.25e-06	0.00159	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—GSTZ1—urinary bladder cancer	5.16e-06	0.00156	CbGpPWpGaD
Meprobamate—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—urinary bladder cancer	5.16e-06	0.00156	CbGpPWpGaD
Meprobamate—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—urinary bladder cancer	5.12e-06	0.00155	CbGpPWpGaD
Meprobamate—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—urinary bladder cancer	5.03e-06	0.00152	CbGpPWpGaD
Meprobamate—GABRB3—BDNF signaling pathway—HRAS—urinary bladder cancer	5.01e-06	0.00152	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—GSTO2—urinary bladder cancer	4.89e-06	0.00148	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—NAT1—urinary bladder cancer	4.89e-06	0.00148	CbGpPWpGaD
Meprobamate—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—urinary bladder cancer	4.81e-06	0.00146	CbGpPWpGaD
Meprobamate—GABRA1—SIDS Susceptibility Pathways—TNF—urinary bladder cancer	4.78e-06	0.00145	CbGpPWpGaD
Meprobamate—ABCB1—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	4.64e-06	0.0014	CbGpPWpGaD
Meprobamate—GABRA6—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	4.58e-06	0.00139	CbGpPWpGaD
Meprobamate—GABRA4—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	4.52e-06	0.00137	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—UGT2B7—urinary bladder cancer	4.47e-06	0.00136	CbGpPWpGaD
Meprobamate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—urinary bladder cancer	4.4e-06	0.00133	CbGpPWpGaD
Meprobamate—ABCB1—Integrated Pancreatic Cancer Pathway—ATM—urinary bladder cancer	4.25e-06	0.00129	CbGpPWpGaD
Meprobamate—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—urinary bladder cancer	4.23e-06	0.00128	CbGpPWpGaD
Meprobamate—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—urinary bladder cancer	4.21e-06	0.00128	CbGpPWpGaD
Meprobamate—ABCB1—Allograft Rejection—TNF—urinary bladder cancer	4.13e-06	0.00125	CbGpPWpGaD
Meprobamate—GABRA6—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	4.05e-06	0.00123	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—CYP4B1—urinary bladder cancer	4.03e-06	0.00122	CbGpPWpGaD
Meprobamate—GABRA5—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	4.02e-06	0.00122	CbGpPWpGaD
Meprobamate—GABRA4—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	4e-06	0.00121	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—GSTZ1—urinary bladder cancer	3.98e-06	0.00121	CbGpPWpGaD
Meprobamate—GABRA3—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	3.94e-06	0.0012	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—GSTZ1—urinary bladder cancer	3.89e-06	0.00118	CbGpPWpGaD
Meprobamate—GABRA2—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	3.88e-06	0.00117	CbGpPWpGaD
Meprobamate—GABRB3—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	3.85e-06	0.00117	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—SLC19A1—urinary bladder cancer	3.8e-06	0.00115	CbGpPWpGaD
Meprobamate—GABRG2—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	3.78e-06	0.00115	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—GSTO2—urinary bladder cancer	3.77e-06	0.00114	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—NAT1—urinary bladder cancer	3.77e-06	0.00114	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	3.71e-06	0.00112	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—PRSS3—urinary bladder cancer	3.71e-06	0.00112	CbGpPWpGaD
Meprobamate—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—urinary bladder cancer	3.69e-06	0.00112	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—NAT1—urinary bladder cancer	3.68e-06	0.00112	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—GSTO2—urinary bladder cancer	3.68e-06	0.00112	CbGpPWpGaD
Meprobamate—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—urinary bladder cancer	3.64e-06	0.0011	CbGpPWpGaD
Meprobamate—GABRA5—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	3.55e-06	0.00108	CbGpPWpGaD
Meprobamate—GABRA6—Neuronal System—HRAS—urinary bladder cancer	3.51e-06	0.00106	CbGpPWpGaD
Meprobamate—GABRA3—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	3.49e-06	0.00106	CbGpPWpGaD
Meprobamate—GABRA4—Neuronal System—HRAS—urinary bladder cancer	3.46e-06	0.00105	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—UGT2B7—urinary bladder cancer	3.45e-06	0.00105	CbGpPWpGaD
Meprobamate—GABRA2—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	3.43e-06	0.00104	CbGpPWpGaD
Meprobamate—GABRB3—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	3.4e-06	0.00103	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—UGT2B7—urinary bladder cancer	3.37e-06	0.00102	CbGpPWpGaD
Meprobamate—GABRG2—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	3.34e-06	0.00101	CbGpPWpGaD
Meprobamate—GABRA1—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	3.31e-06	0.001	CbGpPWpGaD
Meprobamate—ABCB1—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	3.13e-06	0.000949	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—CYP4B1—urinary bladder cancer	3.11e-06	0.000942	CbGpPWpGaD
Meprobamate—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—urinary bladder cancer	3.09e-06	0.000936	CbGpPWpGaD
Meprobamate—GABRA5—Neuronal System—HRAS—urinary bladder cancer	3.08e-06	0.000932	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—CYP4B1—urinary bladder cancer	3.03e-06	0.000919	CbGpPWpGaD
Meprobamate—GABRA3—Neuronal System—HRAS—urinary bladder cancer	3.02e-06	0.000916	CbGpPWpGaD
Meprobamate—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—urinary bladder cancer	3.02e-06	0.000916	CbGpPWpGaD
Meprobamate—GABRA2—Neuronal System—HRAS—urinary bladder cancer	2.97e-06	0.0009	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—TYMP—urinary bladder cancer	2.96e-06	0.000898	CbGpPWpGaD
Meprobamate—GABRB3—Neuronal System—HRAS—urinary bladder cancer	2.95e-06	0.000894	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—SLC19A1—urinary bladder cancer	2.93e-06	0.000889	CbGpPWpGaD
Meprobamate—GABRA1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	2.92e-06	0.000885	CbGpPWpGaD
Meprobamate—GABRG2—Neuronal System—HRAS—urinary bladder cancer	2.9e-06	0.000878	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—SLC19A1—urinary bladder cancer	2.86e-06	0.000868	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—PRSS3—urinary bladder cancer	2.86e-06	0.000867	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—PRSS3—urinary bladder cancer	2.79e-06	0.000846	CbGpPWpGaD
Meprobamate—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—urinary bladder cancer	2.73e-06	0.000827	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—NAT2—urinary bladder cancer	2.68e-06	0.000812	CbGpPWpGaD
Meprobamate—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—urinary bladder cancer	2.64e-06	0.0008	CbGpPWpGaD
Meprobamate—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—urinary bladder cancer	2.64e-06	0.000798	CbGpPWpGaD
Meprobamate—GABRA1—Neuronal System—HRAS—urinary bladder cancer	2.53e-06	0.000767	CbGpPWpGaD
Meprobamate—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—urinary bladder cancer	2.51e-06	0.000761	CbGpPWpGaD
Meprobamate—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—urinary bladder cancer	2.44e-06	0.00074	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—RRM2—urinary bladder cancer	2.31e-06	0.000701	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	2.29e-06	0.000695	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—TYMP—urinary bladder cancer	2.29e-06	0.000693	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—TYMP—urinary bladder cancer	2.23e-06	0.000676	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	2.2e-06	0.000665	CbGpPWpGaD
Meprobamate—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—urinary bladder cancer	2.19e-06	0.000664	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—HPGDS—urinary bladder cancer	2.14e-06	0.000649	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—ENO2—urinary bladder cancer	2.14e-06	0.000649	CbGpPWpGaD
Meprobamate—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—urinary bladder cancer	2.14e-06	0.000649	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—GSTT1—urinary bladder cancer	2.08e-06	0.00063	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—NAT2—urinary bladder cancer	2.07e-06	0.000627	CbGpPWpGaD
Meprobamate—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—urinary bladder cancer	2.04e-06	0.000618	CbGpPWpGaD
Meprobamate—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—urinary bladder cancer	2.02e-06	0.000613	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—NAT2—urinary bladder cancer	2.02e-06	0.000612	CbGpPWpGaD
Meprobamate—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	1.8e-06	0.000545	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—RRM2—urinary bladder cancer	1.78e-06	0.000541	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—RRM2—urinary bladder cancer	1.74e-06	0.000528	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—NQO1—urinary bladder cancer	1.73e-06	0.000523	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—ENO2—urinary bladder cancer	1.65e-06	0.000501	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—HPGDS—urinary bladder cancer	1.65e-06	0.000501	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	1.64e-06	0.000498	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—HPGDS—urinary bladder cancer	1.61e-06	0.000489	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—ENO2—urinary bladder cancer	1.61e-06	0.000489	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—GSTT1—urinary bladder cancer	1.6e-06	0.000486	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	1.58e-06	0.000478	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—GSTT1—urinary bladder cancer	1.56e-06	0.000474	CbGpPWpGaD
Meprobamate—ABCB1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	1.47e-06	0.000444	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—GSTP1—urinary bladder cancer	1.44e-06	0.000436	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—TYMS—urinary bladder cancer	1.34e-06	0.000406	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—NQO1—urinary bladder cancer	1.33e-06	0.000404	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—GSTM1—urinary bladder cancer	1.32e-06	0.000401	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—NCOR1—urinary bladder cancer	1.32e-06	0.000401	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—NQO1—urinary bladder cancer	1.3e-06	0.000394	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	1.29e-06	0.000392	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—GPX1—urinary bladder cancer	1.27e-06	0.000384	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—ERCC2—urinary bladder cancer	1.24e-06	0.000377	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—MTHFR—urinary bladder cancer	1.17e-06	0.000354	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.13e-06	0.000342	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—GSTP1—urinary bladder cancer	1.11e-06	0.000337	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—GSTP1—urinary bladder cancer	1.08e-06	0.000329	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.08e-06	0.000326	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—TYMS—urinary bladder cancer	1.03e-06	0.000313	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—NCOR1—urinary bladder cancer	1.02e-06	0.000309	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—GSTM1—urinary bladder cancer	1.02e-06	0.000309	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—TYMS—urinary bladder cancer	1.01e-06	0.000306	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—NCOR1—urinary bladder cancer	9.97e-07	0.000302	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—GSTM1—urinary bladder cancer	9.97e-07	0.000302	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—GPX1—urinary bladder cancer	9.78e-07	0.000296	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—ERCC2—urinary bladder cancer	9.6e-07	0.000291	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—GPX1—urinary bladder cancer	9.55e-07	0.000289	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—PPARG—urinary bladder cancer	9.49e-07	0.000287	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—ERCC2—urinary bladder cancer	9.37e-07	0.000284	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—CREBBP—urinary bladder cancer	9.11e-07	0.000276	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—MTHFR—urinary bladder cancer	9.03e-07	0.000273	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—MTHFR—urinary bladder cancer	8.81e-07	0.000267	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—PTGS2—urinary bladder cancer	7.46e-07	0.000226	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—PPARG—urinary bladder cancer	7.32e-07	0.000222	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—PPARG—urinary bladder cancer	7.14e-07	0.000216	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—CREBBP—urinary bladder cancer	7.03e-07	0.000213	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—CREBBP—urinary bladder cancer	6.86e-07	0.000208	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—PTEN—urinary bladder cancer	6.51e-07	0.000197	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—EP300—urinary bladder cancer	6.21e-07	0.000188	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—PTGS2—urinary bladder cancer	5.76e-07	0.000174	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—PTGS2—urinary bladder cancer	5.62e-07	0.00017	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—PTEN—urinary bladder cancer	5.02e-07	0.000152	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—PTEN—urinary bladder cancer	4.9e-07	0.000148	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—EP300—urinary bladder cancer	4.79e-07	0.000145	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—EP300—urinary bladder cancer	4.67e-07	0.000142	CbGpPWpGaD
